- Home
- AREB vs PLRZ Comparison
AREB vs PLRZ Comparison
Compare AREB & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREB
- PLRZ
- Stock Information
- Founded
- AREB 2014
- PLRZ 2005
- Country
- AREB United States
- PLRZ Israel
- Employees
- AREB N/A
- PLRZ N/A
- Industry
- AREB Plastic Products
- PLRZ
- Sector
- AREB Industrials
- PLRZ
- Exchange
- AREB Nasdaq
- PLRZ NYSE
- Market Cap
- AREB 2.8M
- PLRZ 2.3M
- IPO Year
- AREB N/A
- PLRZ 2024
- Fundamental
- Price
- AREB $6.29
- PLRZ $0.39
- Analyst Decision
- AREB
- PLRZ
- Analyst Count
- AREB 0
- PLRZ 0
- Target Price
- AREB N/A
- PLRZ N/A
- AVG Volume (30 Days)
- AREB 4.3M
- PLRZ 648.7K
- Earning Date
- AREB 04-11-2025
- PLRZ 02-15-2025
- Dividend Yield
- AREB N/A
- PLRZ N/A
- EPS Growth
- AREB N/A
- PLRZ N/A
- EPS
- AREB N/A
- PLRZ N/A
- Revenue
- AREB $14,447,104.00
- PLRZ N/A
- Revenue This Year
- AREB $45.19
- PLRZ N/A
- Revenue Next Year
- AREB N/A
- PLRZ N/A
- P/E Ratio
- AREB N/A
- PLRZ N/A
- Revenue Growth
- AREB N/A
- PLRZ N/A
- 52 Week Low
- AREB $1.10
- PLRZ $0.28
- 52 Week High
- AREB $231.75
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- AREB 41.52
- PLRZ N/A
- Support Level
- AREB $1.10
- PLRZ N/A
- Resistance Level
- AREB $4.00
- PLRZ N/A
- Average True Range (ATR)
- AREB 1.46
- PLRZ 0.00
- MACD
- AREB 0.95
- PLRZ 0.00
- Stochastic Oscillator
- AREB 70.61
- PLRZ 0.00
About AREB American Rebel Holdings Inc.
American Rebel Holdings Inc develops self-defense, safe storage, and patriotic products. It designs, manufactures, and markets concealed carry products. It offers products ranging in Backpacks, vault doors, and Others.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.